Organic & Biomolecular Chemistry · 2006 · 20 citations · 26 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsLead Compound DesignLigand BindingMolecular DockingPeptidomimetic DesignProtein-ligand BindingProtein-ligand DockingBinding Affinity EnhancementBinding Mode AnalysisBinding StudiesChemical Structure-activity RelationshipsInhibitor Binding AffinityLigand-protein DockingRational DesignViral Entry Inhibitors
We recently described the design and synthesis of a novel CD4 binding peptidomimetic as a potential HIV entry inhibitor with a KD value of approximately 35 microM and a high proteolytic stability [A. T. Neffe and B. Meyer, Angew. Chem., Int. Ed., 2004, 43, 2937-2940]. Based on saturation transfer difference (STD) NMR analyses and docking studies of peptidomimetics we now report the rational design, synthesis, and binding properties of 11 compounds with improved binding affinity. Surface plasmon resonance (SPR) resulted in a KD = 10 microM for the best peptidomimetic XI, whose binding affinity is confirmed by STD NMR (KD = 9 microM). The STD NMR determined binding epitope of the ligand indicates a very similar binding mode as that of the lead structure. The binding studies provide structure activity relationships and demonstrate the utility of this approach.
26
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Angus Dalgleish, Peter C. L. Beverley, Paul R. Clapham et al. · Nature · 1984 · 3.5K citations
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV
David Klatzmann, Éric Champagne, S. Chamaret et al. · Nature · 1984 · 2.4K citations